Clinical Trial Update: Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial investigating the pathophysiologic mechanisms behind arrhythmias and reduced aerobic capacity in Tetralogy of Fallot and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Tetralogy of Fallot

Snippet

Sponsor: Mayo Clinic | Conditions: Tetralogy of Fallot, Congenital Heart Disease | Status: RECRUITING